Role of cyclooxygenases, COX-1 and COX-2, in modulating adipogenesis in 3T3-L1 cells

Hongyun Yan, Abdenaim Kermouni, Mohammed Abdel-Hafez, and David C.W. Lau

Medicine Dept., Julia-McFarlane Diabetes Center, The University of Calgary, Calgary, AB T2N 4N1

Corresponding Author: dcwlau{at}ucalgary.ca

Cyclooxygenase (COX) catalyses the rate limiting step of prostanoid biosynthesis. Two COX isoforms have been identified, COX-1, the constitutive form, and COX-2, the inducible form. While COX-2 has been implicated in body fat regulation, the underlying cellular mechanism remains to be elucidated. The present study was undertaken to examine the potential role of COX in modulating adipogenesis and to dissect the relative contribution of the two isoenzymes in this process. COX-2 was found to be expressed in undifferentiated 3T3-L1 cells and down-regulated during differentiation, whereas the cellular level of COX-1 remained relatively constant. Abrogating the activity of either of these two isoenzymes by selective COX inhibitors accelerated cellular differentiation, suggesting that both COX isoenzymes negatively influenced differentiation. Tumor necrosis factor-a (TNFa) significantly up-regulated COX-2 expression (~2 fold) in differentiating 3T3-L1 cells, whereas similar effect was not observed with COX-1 expression. Abrogating the induced COX-2 activity reversed the TNFa-induced inhibition of differentiation by ~70%, implying a role for COX-2 in mediating TNFa signaling. Hence, both COX isoforms were involved in the negative modulation of adipocyte differentiation. COX-2 appeared to be the main isoform mediating at least part of the negative effects of TNFa.

Add to CiteULike CiteULike Add to Complore Complore Add to Connotea Connotea Add to Del.icio.us Del.icio.us Add to Digg Digg Add to Reddit Reddit Add to Technorati Technorati What's this?

This article has been cited by other articles:

B. Sen, M. Styner, Z. Xie, N. Case, C. T. Rubin, and J. Rubin
Mechanical Loading Regulates NFATc1 and {beta}-Catenin Signaling through a GSK3{beta} Control Node
J. Biol. Chem., December 11, 2009; 284(50): 34607 - 34617.
[Abstract] [Full Text] [PDF]

R. E. Duncan, E. Sarkadi-Nagy, K. Jaworski, M. Ahmadian, and H. S. Sul
Identification and Functional Characterization of Adipose-specific Phospholipase A2 (AdPLA)
J. Biol. Chem., September 12, 2008; 283(37): 25428 - 25436.
[Abstract] [Full Text] [PDF]

M. Dragunow, R. Cameron, P. Narayan, and S. O'Carroll
Image-Based High-Throughput Quantification of Cellular Fat Accumulation
J Biomol Screen, October 1, 2007; 12(7): 999 - 1005.
[Abstract] [PDF]

J. Tirard, J. Gout, A. M. Lefrancois-Martinez, A. Martinez, M. Begeot, and D. Naville
A Novel Inhibitory Protein in Adipose Tissue, the Aldo-Keto Reductase AKR1B7: Its Role in Adipogenesis
Endocrinology, May 1, 2007; 148(5): 1996 - 2005.
[Abstract] [Full Text] [PDF]

R. Martin-Venegas, S. Roig-Perez, R. Ferrer, and J. J. Moreno
Arachidonic acid cascade and epithelial barrier function during Caco-2 cell differentiation
J. Lipid Res., July 1, 2006; 47(7): 1416 - 1423.
[Abstract] [Full Text] [PDF]

R. K. Petersen, C. Jorgensen, A. C. Rustan, L. Froyland, K. Muller-Decker, G. Furstenberger, R. K. Berge, K. Kristiansen, and L. Madsen
Arachidonic acid-dependent inhibition of adipocyte differentiation requires PKA activity and is associated with sustained expression of cyclooxygenases
J. Lipid Res., December 1, 2003; 44(12): 2320 - 2330.
[Abstract] [Full Text] [PDF]

L. Fajas, S. Miard, M. R. Briggs, and J. Auwerx
Selective cyclo-oxygenase-2 inhibitors impair adipocyte differentiation through inhibition of the clonal expansion phase
J. Lipid Res., September 1, 2003; 44(9): 1652 - 1659.
[Abstract] [Full Text] [PDF]